| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 10/02/2008 | WO2008079873A3 Thiazolyl compounds useful as kinase inhibitors |
| 10/02/2008 | WO2008075172A3 Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
| 10/02/2008 | WO2008020211A3 Benzimidazole, benzoxazole and benzothiazole derivatives, optical film comprising them and method of production thereof |
| 10/02/2008 | US20080242863 Process For the Manufacture of a Precursor of Vitamin B1 |
| 10/02/2008 | US20080242716 Ion Channel Modulators |
| 10/02/2008 | US20080242701 Antitumor agents; anticancer agents; cytotoxic activity; angiogenesis inhibitor; leukemia; colorectal cancer; administering by mouth |
| 10/02/2008 | US20080242694 inhibition of a kinase pathway for the treatment of cancer, inflammatory, immunological and metabolic conditions; agents may target two or more kinases of the same/different family; [2-AMINO-1-(2-PHENYLETHYL)ETHYL](5-(6-ISOQUINOLYL)(1,3,4-THIADIAZOL-2-YL))AMINE |
| 10/02/2008 | US20080242676 Drug resistant Mycobacterium tuberculosis |
| 10/02/2008 | US20080242666 e.g. (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-(1-ethylpropyl)-1-[2(hydroxymethyl)benzyl]-piperazine-2,5-dione; preparation by cyclization |
| 10/02/2008 | US20080242658 Inhibitors of Iap |
| 10/02/2008 | US20080242654 Novel compounds as cannabinoid receptor ligands |
| 10/02/2008 | US20080241594 Novel compound and organic thin film transistor |
| 10/02/2008 | CA2682012A1 Substituted pyrrolidinamides, manufacturing and use thereof as medicaments |
| 10/02/2008 | CA2681695A1 2-aminopyridine analogs as glucokinase activators |
| 10/02/2008 | CA2681206A1 8-(heteroarylmethoxy)quinoline compounds as bradykinin b2 receptor modulators |
| 10/02/2008 | CA2681030A1 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 10/02/2008 | CA2680517A1 Novel pyridinecarboxylic acid (2-aminophenyl)amide derivative having urea structure |
| 10/02/2008 | CA2677991A1 Thiazolidine derivatives |
| 10/01/2008 | EP1975169A1 Process for the preparation of ziprasidone |
| 10/01/2008 | EP1975165A1 Substituted pyrrolidinamides, their production and utilisation as medicine |
| 10/01/2008 | EP1975162A1 Oxazolone derivative |
| 10/01/2008 | EP1974608A1 Arylpyridazines as fungicides |
| 10/01/2008 | EP1973904A2 Muscarinic agonists and methods of use thereof |
| 10/01/2008 | EP1973900A1 Hydantoin compounds for the treatment of inflammatory disorders |
| 10/01/2008 | EP1973898A1 Pdf inhibitors |
| 10/01/2008 | EP1973888A1 Isoxazolines for controlling invertebrate pests |
| 10/01/2008 | EP1973886A2 Prokineticin 1 receptor antagonists |
| 10/01/2008 | EP1973884A2 Novel heterocycles |
| 10/01/2008 | EP1420780B1 Cyclopropyl and cyclobutyl epothilone analogs |
| 10/01/2008 | EP1372655B1 Cathepsin cysteine protease inhibitors |
| 10/01/2008 | CN101277946A Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes |
| 10/01/2008 | CN101277945A Indol-3-yl-carbonyl-piperidin and piperazin derivatives |
| 10/01/2008 | CN101277940A 4-oxy-n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 10/01/2008 | CN101277934A Metabotropic glutamate-receptor-potentiating isoindolones |
| 10/01/2008 | CN101274929A Thrombin receptor antagonists |
| 10/01/2008 | CN100422185C Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
| 10/01/2008 | CN100422179C 2-amino-5-benzoylthiazole npy antagonists |
| 10/01/2008 | CN100422178C Process for producing imide compound |
| 10/01/2008 | CN100422173C Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 10/01/2008 | CN100422172C Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 10/01/2008 | CN100422164C Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 10/01/2008 | CN100422160C Novel morpholine derivatives, method for production thereof and pharmaceutical preparations containing said derivatives |
| 10/01/2008 | CN100422158C Inhibitors of Akt activity |
| 10/01/2008 | CN100422151C Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 10/01/2008 | CN100421665C Mitotic kinesin inhibitors |
| 10/01/2008 | CA2654898A1 New chemical compounds |
| 09/30/2008 | US7429667 suc as 5-[4-(2,5-Dichloro-phenoxy)-3-fluoro-phenylamino]-3-hydroxy-N-isopropyl-isothiazole-4-carboxamidine; anticarcinogenic agent |
| 09/30/2008 | US7429660 Induce immunology response; anticancer agents |
| 09/30/2008 | US7429618 substituted triarylmethane compounds for immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 09/30/2008 | US7429601 Tropan-6exo-yl benzilate methobromide or a physiologically acceptable salt or derivative; chronic obstructive pulmonary disease, asthma; urogenital disorders; antihistamine, antispasmodic, and bronchodilator agents |
| 09/30/2008 | US7429599 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| 09/30/2008 | US7429597 Heterobicyclic compound such as quinazoline anticoagulants and factor X inhibitors |
| 09/30/2008 | US7429593 Utilities of amide compounds |
| 09/30/2008 | US7429590 e.g. 2-(4-Fluorophenyl)-7-(1-methylpiperidin-4-yl)-3-(2-methylpyrimidin-4-yl)imidazo[1,2-a]-pyridine; protozoal diseases (toxoplasmosis, malaria, African typanosomiasis, Chagas disease, and opportunistic infections) in mammals and birds; controlling coccidiosis in poultry |
| 09/30/2008 | US7429587 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 09/30/2008 | US7429583 e.g. 8-{2-[1,1-dimethyl-3-(6-methyl-2-oxo-2,3-dihydro-benzimidazol-1-yl)-propylamino]-1-hydroxy-ethyl}-6-hydroxy-4H-benzo[1,4]oxazin-3-one; adrenoreceptor modulator (agonist); respiratory system diseases: COPD, asthma, cystic fibrosis, bronchitis, bronchiectasis; sustained release |
| 09/30/2008 | US7429581 Pyrazole-derivatives as factor Xa inhibitors |
| 09/30/2008 | US7429579 antagonism/inhibition, of the D3 receptor; substance abuse. |
| 09/30/2008 | CA2417417C Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 09/25/2008 | WO2008115369A2 Inhibitors of focal adhesion kinase |
| 09/25/2008 | WO2008114971A1 Novel benzamide derivatives and process for the preparation thereof |
| 09/25/2008 | WO2008114157A1 Amino- pyridine derivatives as s1p1 /edg1 receptor agonists |
| 09/25/2008 | WO2008114023A2 Phthalazinone derivatives |
| 09/25/2008 | WO2008113795A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 09/25/2008 | WO2008097428A3 Compounds and compositions as modulators of gpr119 activity |
| 09/25/2008 | WO2008091624A3 Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof |
| 09/25/2008 | WO2007146349A3 Cgrp receptor antagonists |
| 09/25/2008 | US20080234327 2-(benzo[d]thiazol-2-yl)-4,5-dihydro-2H-benzo[e]indazol-1-ol; hereditary hemochromatosis, anemias |
| 09/25/2008 | US20080234273 Such as 3-{[4-(azetidin-1-ylcarbonyl)-2-chlorophenyl]oxy}-5-({(1S)-2-[(difluoromethyl)oxy]-1-methylethyl}oxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinases (Glk) |
| 09/25/2008 | US20080234268 Effective for prophylaxis and treatment of diseases, such as ("c-Met") hepatocyte growth factor receptor mediated diseases; N-(4-(3-amino-1H-indazol-4-yl)-3-fluorophenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide; treatment of neoplasia selected from lung, breast, colon cancer |
| 09/25/2008 | US20080234263 Antiproliferative agent in the prevention or treatment of tumors which are sensitive to inhibition of EGF and erbB receptor tyrosine kinases;1-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}methyl)-L-prolinamide |
| 09/25/2008 | US20080234250 Heterocyclic Condensed Compounds Useful as Antidiuretic Agents |
| 09/25/2008 | CA2682195A1 Aminopyrimidines useful as kinase inhibitors |
| 09/25/2008 | CA2681516A1 Compounds useful as inhibitors of janus kinases |
| 09/25/2008 | CA2681015A1 Inhibitors of focal adhesion kinase |
| 09/25/2008 | CA2679260A1 Novel benzamide derivatives and process for the preparation thereof |
| 09/25/2008 | CA2679138A1 Amino-pyridine derivatives as s1p1/edg1 receptor agonists |
| 09/24/2008 | EP1972623A1 Arylpyridazines as fungicides |
| 09/24/2008 | EP1971603A2 SULFOXIMINE DERIVATIVES AS p38 MAP KINASE INHIBITORS |
| 09/24/2008 | EP1971601A2 N4-phenyl-quinazoline-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
| 09/24/2008 | EP1971597A2 N-(5-membered heteroaromatic ring)-amido anti-viral compounds |
| 09/24/2008 | EP1971596A2 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands |
| 09/24/2008 | EP1971594A2 Substituted pyrazalones |
| 09/24/2008 | EP1971583A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 09/24/2008 | EP1971582A1 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 09/24/2008 | EP1971580A1 Piperazine compounds with a herbicidal action |
| 09/24/2008 | EP1971576A2 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 09/24/2008 | EP1971368A2 Compositions and methods for treating thrombocytopenia |
| 09/24/2008 | EP1814879B1 Derivatives of 4,7-dioxobenzothiazole-2-carboxamides, preparation method thereof and therapeutic uses of same |
| 09/24/2008 | EP1723116B1 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors |
| 09/24/2008 | EP1513520B1 Substituted pyrrolines as kinase inhibitors |
| 09/24/2008 | EP1322650B1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
| 09/24/2008 | CN101273038A Macrocylic inhibitors of hepatitis C virus |
| 09/24/2008 | CN101273035A Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/24/2008 | CN101273034A Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/24/2008 | CN101273033A 4- (iH-indazol-s-yl-amino)-quinazoline compounds as ERBB receptor tyrosine kinase inhibitors for the treatment of cancer |
| 09/24/2008 | CN101273032A Pyrazine kinase inhibitors |
| 09/24/2008 | CN101273029A Bicyclic bisamide derivatives and use thereof as insecticides |
| 09/24/2008 | CN101273023A 5-substituted thiazol-2-yl amino compounds and compositions as protein kinase inhibitors |
| 09/24/2008 | CN101273019A Novel benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use especially as C-Met inhibitors |